Development of Medical Countermeasures for Biothreat Agents, Antimicrobial-Resistant Infections an Emerging Infectious Diseases
Award Notice Posted
- Solicitation number
- HHS-NIH-NIAID-BAA2021-1
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Blacksmith Medicines, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93022C00060 Federal contract award
Notice details come from SAM.gov. Updated .
About this opportunity
This cost-reimbursement contract for $17,277,291 was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to FORGE THERAPEUTICS INC on September 21, 2022 to support the development of medical countermeasures for biothreat agents, antimicrobial-resistant infections and emerging infectious diseases. The contract was awarded under full and open competition and selected a cost-reimbursement type given costs could not be adequately defined at the time of award.
Notice text
This cost-reimbursement contract award was made under full and open competition. This type of contract was selected because costs cannot be adequately defined at the time of contract award.
Awarded contract 75N93022C00060 to FORGE THERAPEUTICS INC for 17277291.00 on 2022-09-21.
Notice history
6 of 9 notices listed here. See the rest on GovTribe.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity